PENS 510(k) For Pain Treatment Follows On Heels Of Favorable JAMA Study
This article was originally published in The Gray Sheet
Executive Summary
PENS, LLC plans to submit a 510(k) in the next few weeks for the PENS percutaneous electrical nerve stimulation device for a broad "treatment of pain" indication.